• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清和糖皮质激素依赖性激酶 1 诱导的细胞迁移依赖于粘着斑蛋白,并受膜雄激素受体调节。

Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor.

机构信息

Department of Physiology, University of Tübingen, Tübingen, Germany.

出版信息

FEBS J. 2012 Apr;279(7):1231-42. doi: 10.1111/j.1742-4658.2012.08515.x. Epub 2012 Feb 24.

DOI:10.1111/j.1742-4658.2012.08515.x
PMID:22309306
Abstract

The serum- and glucocorticoid-dependent kinases 1-3 (SGK1-3) are downstream effectors of phosphatidylinositol 3-kinases, implicated in various cell responses including colon cancer tumorigenesis in mice. Here, we investigated the role of SGK1 in the regulation of cell motility. Using Caco-2 colon tumor and HEK293 embryonic kidney cells, we report that transfection with the constitutively active SGK1 mutant (SGK1-SD) significantly enhanced cell motility. The cell-adhesion protein vinculin was effectively dephosphorylated in SGK1-SD-transfected cells. Treatment of the cells with phosphatase inhibitors restored vinculin phosphorylation and inhibited cell migration, indicating a significant role for vinculin phosphorylation in SGK1-induced motility. SGK1-SD-enhanced cell motility was inhibited by activation of membrane androgen-binding sites (mAR) via testosterone-conjugates in both cell lines, whereas intracellular androgen receptor (iAR)-silencing and flutamide treatment revealed that these effects were clearly independent of the interaction of SGK1 with the classical androgen receptors (iAR). More importantly, mAR activation restored vinculin phosphorylation in SGK1-SD-transfected cells, whereas silencing of vinculin fully reversed the mAR-induced inhibition of the migratory capacity, implying that this protein is directly involved in cell motility regulation by SGK1 and mAR. This study indicates for the first time that SGK1 regulates cell migration via vinculin dephosphorylation, a mechanism that is controlled by mAR function.

摘要

血清和糖皮质激素依赖性激酶 1-3(SGK1-3)是磷脂酰肌醇 3-激酶的下游效应物,参与多种细胞反应,包括在小鼠中的结肠癌发生。在这里,我们研究了 SGK1 在调节细胞迁移中的作用。使用 Caco-2 结肠肿瘤和 HEK293 胚胎肾细胞,我们报告说,用组成型活性 SGK1 突变体(SGK1-SD)转染显着增强了细胞迁移。SGK1-SD 转染细胞中的细胞黏附蛋白 vinculin 被有效去磷酸化。用磷酸酶抑制剂处理细胞可恢复 vinculin 的磷酸化并抑制细胞迁移,表明 vinculin 磷酸化在 SGK1 诱导的迁移中起重要作用。SGK1-SD 增强的细胞迁移可通过两种细胞系中的睾酮缀合物激活膜雄激素结合位点(mAR)而被抑制,而细胞内雄激素受体(iAR)沉默和氟他胺处理表明这些作用明显独立于 SGK1 与经典雄激素受体(iAR)的相互作用。更重要的是,mAR 激活恢复了 SGK1-SD 转染细胞中的 vinculin 磷酸化,而 vinculin 沉默则完全逆转了 mAR 诱导的迁移能力抑制,这表明该蛋白直接参与了 SGK1 和 mAR 调节的细胞迁移。这项研究首次表明,SGK1 通过 vinculin 的去磷酸化来调节细胞迁移,该机制受 mAR 功能的控制。

相似文献

1
Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor.血清和糖皮质激素依赖性激酶 1 诱导的细胞迁移依赖于粘着斑蛋白,并受膜雄激素受体调节。
FEBS J. 2012 Apr;279(7):1231-42. doi: 10.1111/j.1742-4658.2012.08515.x. Epub 2012 Feb 24.
2
Inhibition of SGK1 enhances mAR-induced apoptosis in MCF-7 breast cancer cells.抑制SGK1可增强mAR诱导的MCF-7乳腺癌细胞凋亡。
Cancer Biol Ther. 2015;16(1):52-9. doi: 10.4161/15384047.2014.986982.
3
Negative regulation of SEK1 signaling by serum- and glucocorticoid-inducible protein kinase 1.血清和糖皮质激素诱导蛋白激酶1对SEK1信号的负调控
EMBO J. 2007 Jul 11;26(13):3075-85. doi: 10.1038/sj.emboj.7601755. Epub 2007 Jun 14.
4
SGK1 sensitivity of platelet migration.血小板迁移的血清/糖皮质激素调节激酶1敏感性
Cell Physiol Biochem. 2012;30(1):259-68. doi: 10.1159/000339062. Epub 2012 Jun 19.
5
Serum- and glucocorticoid-inducible kinase 1 enhances zif268 expression through the mediation of SRF and CREB1 associated with spatial memory formation.血清和糖皮质激素诱导激酶1通过与空间记忆形成相关的血清反应因子(SRF)和环磷腺苷效应元件结合蛋白1(CREB1)的介导来增强zif268表达。
J Neurochem. 2008 May;105(3):820-32. doi: 10.1111/j.1471-4159.2007.05186.x. Epub 2007 Dec 13.
6
Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival.血清/糖皮质激素诱导蛋白激酶-1促进雄激素受体依赖性细胞存活。
Cell Death Differ. 2007 Dec;14(12):2085-94. doi: 10.1038/sj.cdd.4402227. Epub 2007 Oct 12.
7
Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling.在结肠癌中,膜雄激素受体的激活抑制了 Akt/bad 这一存活信号,在体外和体内均如此,同时通过 vinculin/actin 信号通路阻断了迁移。
Mol Med. 2011 Jan-Feb;17(1-2):48-58. doi: 10.2119/molmed.2010.00120. Epub 2010 Oct 15.
8
Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite formation through microtubule depolymerization by SGK1 and by SGK1 phosphorylation of tau.血清和糖皮质激素诱导激酶1(SGK1)通过SGK1介导的微管解聚以及tau蛋白的SGK1磷酸化作用来增加神经突的形成。
Mol Cell Biol. 2006 Nov;26(22):8357-70. doi: 10.1128/MCB.01017-06. Epub 2006 Sep 18.
9
Colorectal carcinoma cells--regulation of survival and growth by SGK1.结直肠癌细胞——SGK1 对其存活和生长的调节。
Int J Biochem Cell Biol. 2010 Oct;42(10):1571-5. doi: 10.1016/j.biocel.2010.05.016. Epub 2010 Jun 9.
10
Induction of serum- and glucocorticoid-induced kinase-1 (SGK1) by cAMP regulates increases in alpha-ENaC.环磷酸腺苷(cAMP)诱导血清和糖皮质激素诱导激酶-1(SGK1)可调节α-上皮钠通道(α-ENaC)的增加。
J Cell Physiol. 2008 Dec;217(3):632-42. doi: 10.1002/jcp.21534.

引用本文的文献

1
Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.通过糖皮质激素诱导 SGK1 影响三阴性乳腺癌患者的临床转归。
Breast Cancer Res Treat. 2023 Aug;200(3):323-335. doi: 10.1007/s10549-023-06990-4. Epub 2023 Jun 7.
2
Machine learning models for predicting steroid-resistant of nephrotic syndrome.用于预测肾病综合征类固醇耐药的机器学习模型。
Front Immunol. 2023 Jan 26;14:1090241. doi: 10.3389/fimmu.2023.1090241. eCollection 2023.
3
SGK1 in Cancer: Biomarker and Drug Target.癌症中的血清和糖皮质激素诱导激酶1:生物标志物与药物靶点。
Cancers (Basel). 2022 May 12;14(10):2385. doi: 10.3390/cancers14102385.
4
SGK1 in Human Cancer: Emerging Roles and Mechanisms.人类癌症中的SGK1:新出现的作用和机制
Front Oncol. 2021 Jan 19;10:608722. doi: 10.3389/fonc.2020.608722. eCollection 2020.
5
The Enigmatic Role of Serum & Glucocorticoid Inducible Kinase 1 in the Endometrium.血清与糖皮质激素诱导激酶1在子宫内膜中的神秘作用
Front Cell Dev Biol. 2020 Oct 21;8:556543. doi: 10.3389/fcell.2020.556543. eCollection 2020.
6
The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star.血清和糖皮质激素诱导激酶1(SGK1)在癌症治疗中的前景:一颗冉冉升起的新星。
Ther Adv Med Oncol. 2020 Jul 15;12:1758835920940946. doi: 10.1177/1758835920940946. eCollection 2020.
7
Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress.血清和糖皮质激素诱导激酶1与细胞应激反应
Cell Stress. 2018 Dec 2;3(1):1-8. doi: 10.15698/cst2019.01.170.
8
Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion.miR-576-3p 通过靶向 SGK1 抑制肺腺癌细胞迁移和侵袭。
Mol Cancer Res. 2019 Jan;17(1):289-298. doi: 10.1158/1541-7786.MCR-18-0364. Epub 2018 Sep 26.
9
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT.SGK1 抑制诱导的自噬通过逆转 EMT 来损害前列腺癌转移。
J Exp Clin Cancer Res. 2018 Apr 2;37(1):73. doi: 10.1186/s13046-018-0743-1.
10
Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.致癌性MNK信号传导调控转移抑制因子NDRG1。
Oncotarget. 2017 Jul 11;8(28):46121-46135. doi: 10.18632/oncotarget.17555.